Magnetic resonance angiography in diagnostic long-term follow-up of primary patency of the MOTIV drug-eluting bioresorbable vascular scaffold in the region below the knee: 5 years of experience.
<h4>Purpose</h4>Treatment of peripheral artery disease (PAD) in the region below the knee (BTK) is dissatisfying as failure of treated target lesions (TLF) is frequent and diagnostic imaging is often challenging. In the BTK-region metallic drug-eluting stents (mDES) yielded best results...
Saved in:
Main Authors: | Christian Nasel, Mario Kirschner, Karoline Rizzi, Nicola Schweinhammer, Ewald Moser |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0313696 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Moving away from metal: Step toward the future with bioresorbable vascular scaffolds and novel antiproliferative agents
by: Blair E. Warren, MD, MSCS, et al.
Published: (2025-01-01) -
Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents
by: Piotr Rola, et al.
Published: (2021-01-01) -
Compartment Syndrome following Below-Knee Amputation
by: Adam S. Gerry, et al.
Published: (2022-01-01) -
Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium
by: Andrejs Erglis, et al.
Published: (2022-01-01) -
Regulation and Maintenance of Vascular Tone and Patency in Cardiovascular Health and Disease
by: John W. Calvert, et al.
Published: (2012-01-01)